Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Decibel Therapeutics, Inc. (DBTX)
|
Add to portfolio |
|
|
|
| Price: |
$4.93
| | Metrics |
| OS: |
25.1
|
M
| |
|
|
| Market cap: |
$124
|
M
| |
|
|
|
Net cash:
|
$78.3
|
M
| |
$3.12
|
per share
|
|
EV:
|
$45.6
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 0.0 | 39.9 | 29.4 | 26.2 |
| Revenue growth | -100.0% | 35.6% | 12.4% | |
| Cost of goods sold | 0.0 | 0.0 | 44.1 | 37.9 |
| Gross profit | 0.0 | 39.9 | -14.7 | -11.7 |
| Gross margin | | 100.0% | -49.9% | -44.7% |
| Research and development | 29.8 | 25.3 | | |
| General and administrative | 20.4 | 14.2 | 14.7 | 11.7 |
| EBIT | -50.2 | -39.3 | -44.1 | -37.9 |
| EBIT margin | | -98.5% | -149.9% | -144.7% |
| Pre-tax income | -50.0 | -39.3 | -42.7 | -36.2 |
| Income taxes | 1.8 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 0.0% | 0.0% |
| Net income | -54.1 | -35.3 | -42.7 | -36.2 |
| Net margin | | -88.5% | -145.1% | -138.2% |
| |
| Diluted EPS | ($2.49) | ($19.65) | ($0.12) | ($0.15) |
| Shares outstanding (diluted) | 21.7 | 1.8 | 370.1 | 247.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|